<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31212" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin A Toxicity</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Olson</surname>
            <given-names>Jazmine M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ameer</surname>
            <given-names>Muhammad Atif</given-names>
          </name>
          <aff>Suburban Community Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jazmine Olson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Atif Ameer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31212.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Vitamin A plays a crucial role in regulating various physiological processes of the body and maintaining vision and immune system function to support skin health and cell growth.&#x000a0;Although vitamin A is essential for the body, excessive intake can pose various adverse effects, disrupting the body's equilibrium and overall well-being.&#x000a0;Vitamin A toxicity, also known as hypervitaminosis A, can result from either the excessive consumption of vitamin A and related compounds or its topical application.&#x000a0;This activity describes the causes, evaluation, management, treatment, and prevention of vitamin A toxicity, emphasizing the essential role of the interprofessional healthcare team in enhancing care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the risk factors associated with excessive vitamin A intake, considering dietary sources, supplements, and medication history.</p></list-item><list-item><p>Assess laboratory findings, including serum vitamin A levels, liver function tests, lipid profiles, and hematological parameters, to diagnose and monitor vitamin A toxicity in patients.</p></list-item><list-item><p>Select and recommend appropriate treatment modalities, alternative therapies, or supplements to patients based on the severity and presentation of vitamin A toxicity.</p></list-item><list-item><p>Coordinate with the interprofessional healthcare team to guide pregnant women about safe vitamin A use during pregnancy and prevent teratogenic malformations.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31212&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31212">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31212.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vitamin A is essential for maintaining the body's vision, cell division, reproduction, and immune function. Vitamin A belongs to the category of lipid-soluble compounds called retinoic acids.&#x000a0;Beta-carotene is the most well-known form of 2 clinically significant forms of vitamin A: preformed vitamin A and provitamin A carotenoids.&#x000a0;Mammals metabolize carotenoids into active vitamin A.&#x000a0;Preformed vitamin A encompasses metabolically active compounds such as retinol, retinal, retinoic acid, and retinyl esters.&#x000a0;Although essential for overall health, excessive consumption of preformed vitamin A can&#x000a0;lead to acute and chronic toxicity.&#x000a0;The condition characterized by elevated levels of vitamin A in the body is referred to as hypervitaminosis A.&#x000a0;Vitamin A, also known as teratogen, is&#x000a0;capable of causing severe malformations. This article comprehensively reviews the prevention, presentation, laboratory findings, and treatment of the 3 recognized syndromes of vitamin A toxicity: acute, chronic, and teratogenic.</p>
      </sec>
      <sec id="article-31212.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hypervitaminosis A is relatively uncommon and usually arises from excessive supplementation or medication usage. The primary cause of toxicity is the consumption of substantial quantities of vitamin A through dietary supplements and foods.&#x000a0;This usually occurs when individuals consume high doses of vitamin A without proper medical supervision. Most diets contain a combination of preformed vitamin A and provitamin A carotenoids. Preformed vitamin A is derived from animal sources and is found in egg yolks, butter, chicken, beef, organ meats, fish, fish oils, and fortified foods.<xref ref-type="bibr" rid="article-31212.r1">[1]</xref> Preformed vitamin A is readily absorbed in the small intestine and subsequently stored in the liver.&#x000a0;Therefore, excessive intake of dietary preformed vitamin A from animal-based sources and supplements can contribute to the risk of toxicity.&#x000a0;</p>
        <p>Provitamin A carotenoids, such as beta-carotene, are plant pigments that the body converts into active vitamin A. These carotenoids are plentiful in leafy greens and vibrantly colored vegetables and fruits, including carrots, sweet potatoes, and papayas.<xref ref-type="bibr" rid="article-31212.r2">[2]</xref> The absorption of provitamin A is variable and subject to feedback regulation, making it unlikely to lead to toxicity with excessive intake.<xref ref-type="bibr" rid="article-31212.r3">[3]</xref> Certain dermatological medications, such as isotretinoin, contain analogs of vitamin A. Prolonged or excessive usage of these medications can lead to an accumulation of vitamin A stores, resulting in hypervitaminosis A, toxicity, and teratogenic effects.</p>
        <p>The recommended daily allowance (RDA) for vitamin A is measured in retinol activity equivalents (RAE) to account for the different bioactivities of retinol and provitamin A carotenoids. Notably, 1&#x000a0;RAE is equivalent to 1 mcg of retinol or 3 International units (IU).</p>
        <p>The RDA for vitamin A is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>700 RAE for adult women</p>
          </list-item>
          <list-item>
            <p>900 RAE for adult men</p>
          </list-item>
          <list-item>
            <p>750&#x000a0;to 770 RAE for pregnant women</p>
          </list-item>
          <list-item>
            <p>1200&#x000a0;to 1300 RAE for lactating women</p>
          </list-item>
        </list>
        <p>The tolerable upper intake levels (UL) for vitamin A have been established to prevent toxicity. The UL of vitamin A for adults is 3000 RAE per day, including preformed vitamin A from foods and supplements and the amount that can be converted from plant-based sources such as beta-carotene. The consumption of preformed vitamin A from dietary supplements in developed countries frequently surpasses the RDA.<xref ref-type="bibr" rid="article-31212.r4">[4]</xref></p>
      </sec>
      <sec id="article-31212.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Few published reports of vitamin A toxicity have been published, with fewer than 10 cases per year documented from 1976 to 1987.<xref ref-type="bibr" rid="article-31212.r5">[5]</xref> Infants and children are at a higher risk of toxicity due to their smaller body size and reduced tolerance for high doses.<xref ref-type="bibr" rid="article-31212.r6">[6]</xref>&#x000a0;Accidental ingestion of vitamin A supplements by children is a common cause of acute toxicity. There is no substantial difference in the occurrence of vitamin A toxicity between males and females. However, pregnant women are at risk if they take high doses of vitamin supplements.</p>
        <p>Excessive supplement intake typically occurs in developed countries when individuals exceed the RDA.<xref ref-type="bibr" rid="article-31212.r4">[4]</xref>&#x000a0;Supplementation programs have been implemented in regions where vitamin deficiency is a significant public health concern. Moreover, toxicity can arise if dosing guidelines are not carefully followed.<xref ref-type="bibr" rid="article-31212.r7">[7]</xref><xref ref-type="bibr" rid="article-31212.r8">[8]</xref> Populations heavily reliant on liver-based food sources rich in vitamin A, such as polar bear liver and chicken liver, face an increased risk of vitamin A toxicity. However, only rare cases of this phenomenon are reported in the published literature, and it is not&#x000a0;considered a significant&#x000a0;public health concern.<xref ref-type="bibr" rid="article-31212.r9">[9]</xref><xref ref-type="bibr" rid="article-31212.r10">[10]</xref><xref ref-type="bibr" rid="article-31212.r11">[11]</xref></p>
      </sec>
      <sec id="article-31212.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The symptoms of systemic vitamin A toxicity vary depending on the severity and duration of excessive intake. The 3 recognized syndromes of vitamin A toxicity are acute, chronic, and teratogenic.</p>
        <p>Acute systemic vitamin A toxicity typically arises when an individual consumes over 100,000 RAE within a short period, often from supplements or high-dose medications. The toxicity symptoms include nausea, vomiting, headache, dizziness, irritability, blurred vision, and muscular incoordination.&#x000a0;Acute toxicity is rare and is more likely to occur after consuming synthetic forms of vitamin A, such as the retinoid medication isotretinoin. Mucocutaneous effects include cheilitis and dryness of lips and oral, ophthalmic, and nasal mucosa. The&#x000a0;suggested mechanism involves decreased sebum production, reduced epidermal thickness, and altered barrier function. Additional cutaneous effects include dry skin, pruritus, peeling of the palms and soles, and fissuring of the fingertips. Higher doses of vitamin A may lead to telogen effluvium. Severe cases may manifest with bone pain and increased intracranial pressure.</p>
        <p>Chronic vitamin A toxicity is associated with&#x000a0;prolonged ingestion of excessive&#x000a0;vitamin A, typically exceeding 8000 RAE per day. This condition can develop after consuming substantial quantities of animal-based foods rich in preformed vitamin A, such as liver, or through the prolonged use of high-dose vitamin A supplements.<xref ref-type="bibr" rid="article-31212.r12">[12]</xref>&#x000a0;The toxicity symptoms include dry, cracked&#x000a0;skin, hair loss, brittle nails, fatigue, loss of appetite, bone and joint pain, and&#x000a0;hepatomegaly.&#x000a0;Chronic retinoid toxicity affects various organ systems. Bone-related effects include bone spurs, calcinosis, and bone resorption, leading to hypercalcemia, osteoporosis, and hip fractures.<xref ref-type="bibr" rid="article-31212.r13">[13]</xref><xref ref-type="bibr" rid="article-31212.r14">[14]</xref>&#x000a0;Central nervous system effects include headache, nausea, and vomiting.</p>
        <p>Pseudotumor cerebri syndrome has been&#x000a0;associated with&#x000a0;vitamin A toxicity.<xref ref-type="bibr" rid="article-31212.r15">[15]</xref> Hypothyroidism, reversible upon discontinuation of therapy, was observed in 40% of patients during clinical trials for cutaneous T-cell lymphoma with bexarotene, a derivative of vitamin A.<xref ref-type="bibr" rid="article-31212.r16">[16]</xref>&#x000a0;Reversible renal dysfunction with elevated serum creatinine&#x000a0;has been observed&#x000a0;after etretinate use, but not after isotretinoin use.<xref ref-type="bibr" rid="article-31212.r17">[17]</xref>&#x000a0;Etretinate, a psoriasis medication,&#x000a0;is no longer&#x000a0;prescribed in most countries because of its teratogenic effects.</p>
        <p>Hypertriglyceridemia is the most common laboratory abnormality associated with oral retinoid use. Triglyceride, low-density lipoprotein, and total&#x000a0;cholesterol levels&#x000a0;increase&#x000a0;in many patients using bexarotene, isotretinoin, etretinate, and acitretin.<xref ref-type="bibr" rid="article-31212.r18">[18]</xref><xref ref-type="bibr" rid="article-31212.r19">[19]</xref>&#x000a0;Elevated serum transaminases may also occur with oral retinoid usage, more often with etretinate or acitretin compared to isotretinoin and bexarotene. These levels typically show an increase within 2 to 8 weeks after the initiation of therapy, followed by normalization over the subsequent 2 to 4 weeks. Prolonged liver damage can include fibrosis and cirrhosis.<xref ref-type="bibr" rid="article-31212.r20">[20]</xref> No definitive causal association has been established between isotretinoin and depression, psychosis, or suicide attempts, although such a link had been previously suggested.<xref ref-type="bibr" rid="article-31212.r21">[21]</xref></p>
        <p>The teratogenic effects of vitamin A intake were first discovered in animal studies during the 1950s. Subsequently, extensive research has been conducted to elucidate the underlying causes of the effects.<xref ref-type="bibr" rid="article-31212.r22">[22]</xref>&#x000a0;Excessive vitamin A consumption during pregnancy has been associated with various congenital malformations in humans. The disabilities associated with this condition include abnormalities in the central nervous system, such as microcephaly and hydrocephalus; cardiac issues, such as transposition of the great vessels; craniofacial deformities, such as cleft lip and palate; limb abnormalities; and urinary tract disorders.<xref ref-type="bibr" rid="article-31212.r5">[5]</xref><xref ref-type="bibr" rid="article-31212.r3">[3]</xref>&#x000a0;</p>
        <p>Vitamin A is critical for regulating gene expression and guiding cell differentiation during embryonic development. The embryo is particularly susceptible to the teratogenic effects of excessive amounts of vitamin A during the first trimester, which is a phase marked by rapid organogenesis. Teratogenic&#x000a0;effects are primarily associated with high doses of retinoid medications such as isotretinoin rather than dietary sources of vitamin A. A minimum safe dose of oral retinoids during pregnancy has not been established. Isotretinoin is estimated to increase the risk of fetal malformations by 25-fold.<xref ref-type="bibr" rid="article-31212.r5">[5]</xref> The mechanism is believed to be linked to a toxic effect on neural crest cells, possibly affecting the regulation of axial patterning in the embryo via the expression of the homeobox gene <italic toggle="yes">Hoxb-1</italic>.<xref ref-type="bibr" rid="article-31212.r23">[23]</xref>&#x000a0;</p>
        <p>Pregnant women should refrain from using oral retinoid medications and excessive vitamin A supplements to mitigate the risk of vitamin A-related malformations. They should consult healthcare professionals and prenatal care providers to ensure proper prenatal nutrition and avoid drugs or supplements that are contraindicated during pregnancy. Prescribers should only recommend oral retinoids to women of childbearing age who are not pregnant and use reliable birth control methods to prevent the potential risk of vitamin A-related teratogenic effects.&#x000a0;</p>
      </sec>
      <sec id="article-31212.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Hypervitaminosis A affects multiple organ systems of the body and can damage the liver, bones, central nervous system, and skin. The specific histopathological findings differ based on the severity and duration of the toxicity, some of which are listed below.</p>
        <p><bold>Liver:</bold> Hepatic steatosis, hepatocellular injury, and fibrosis with collagen deposits</p>
        <p><bold>Bone:</bold> Osteoporosis and thickening of cortical bone</p>
        <p><bold>Central nervous system:</bold> Pseudotumor cerebri and cerebral edema</p>
        <p><bold>Skin:</bold> Exfoliative dermatitis and epidermal hyperplasia&#x000a0;<xref ref-type="bibr" rid="article-31212.r24">[24]</xref><xref ref-type="bibr" rid="article-31212.r25">[25]</xref></p>
      </sec>
      <sec id="article-31212.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>The toxicokinetics of vitamin A toxicity involve its absorption, distribution, metabolism, and elimination from the body.</p>
        <p><bold>Absorption:</bold>&#x000a0;Dietary vitamin A is sourced from 2 main categories: preformed vitamin A, including retinol and retinyl esters, which are found in animal-derived products and supplemented foods, and provitamin A carotenoids present in fruits and vegetables. High-fat meals enhance the absorption of vitamin A in the small intestine.</p>
        <p><bold>Distribution:</bold>&#x000a0;After absorption, vitamin A is transported to the liver, where it is stored as retinyl esters. From there,&#x000a0;it is&#x000a0;released into the bloodstream bound to retinol-binding protein (RBP) and transthyretin. These carrier proteins help transport vitamin A to target tissues, including the eyes, skin, and&#x000a0;other organs.</p>
        <p><bold>Metabolism:</bold>&#x000a0;Retinol is converted into its active forms, retinal and retinoic acid, within target tissues.&#x000a0;Lecithin retinol acyltransferase (LRAT) is the enzyme responsible for catalyzing retinoid esterification for storage in the liver.<xref ref-type="bibr" rid="article-31212.r26">[26]</xref>&#x000a0;Cellular&#x000a0;RBP&#x000a0;assists LRAT in regulating retinoid uptake and metabolism. These 2 proteins are essential in the metabolism&#x000a0;of retinoids, which may be responsible for the toxic effects of vitamin A.</p>
        <p><bold>Elimination:</bold> Fat-soluble vitamin A and its metabolites are primarily excreted through bile and feces, with only a small portion being eliminated in the urine.&#x000a0;</p>
      </sec>
      <sec id="article-31212.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The medical history will likely reveal excessive consumption of vitamin A-rich foods, supplements, or oral retinoid medications. Symptoms&#x000a0;include blurred vision, headaches, dry skin, hair loss, fatigue, and bone pain. Typical physical examination findings may include dryness of the conjunctiva and mucous membranes, scaly skin, alopecia, papilledema, bone tenderness, and hepatomegaly.&#x000a0;</p>
        <p>Patients with a history of using topical vitamin A derivatives will likely exhibit localized skin peeling and erythema, but systemic signs and symptoms are not expected.&#x000a0;</p>
      </sec>
      <sec id="article-31212.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A patient's history and physical examination findings guide the selection of diagnostic studies. Patients with persistent headaches&#x000a0;while taking vitamin A medications should&#x000a0;be evaluated for increased intracranial pressure and pseudotumor cerebri syndrome.</p>
        <p>Laboratory findings obtained during assessing patients with vitamin A toxicity can reveal several abnormalities, a few of which are mentioned below.</p>
        <p><bold>Serum vitamin A levels:</bold>&#x000a0;The serum vitamin A levels exceed 80 mcg/dL.</p>
        <p><bold>Liver function tests:</bold>&#x000a0;Elevated levels of alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) indicate potential hepatic damage or inflammation.</p>
        <p><bold>Serum lipids:</bold>&#x000a0;Increased levels of triglycerides and cholesterol are observed.</p>
        <p><bold>Hematological abnormalities:</bold>&#x000a0;The identified abnormalities in the blood include leukocytosis, thrombocytopenia, and anemia.</p>
        <p><bold>Bone markers:</bold> Increased levels of&#x000a0;ALP are associated with bone turnover.</p>
        <p><bold>Renal function:</bold> Elevations of blood urea nitrogen and creatinine occur.</p>
        <p><bold>Electrolyte imbalances:</bold> Alterations in electrolyte levels, such as sodium, potassium, and calcium occur.</p>
        <p>Some patients require laboratory testing to monitor their condition. Individuals&#x000a0;taking isotretinoin should undergo regular lipid level checks.<xref ref-type="bibr" rid="article-31212.r27">[27]</xref> Elevations in liver enzymes are usually mild and reversible, although ALT and AST may need to be monitored based on the dosage and any comorbidities the patient may have.<xref ref-type="bibr" rid="article-31212.r28">[28]</xref></p>
        <p>Women of childbearing age must have 2 negative pregnancy tests, conducted 30 days apart, before initiating isotretinoin treatment. Additional testing during and immediately after discontinuing the treatment is also necessary.<xref ref-type="bibr" rid="article-31212.r29">[29]</xref>&#x000a0;</p>
        <p>Free T4 should be monitored both before and during treatment with bexarotene.<xref ref-type="bibr" rid="article-31212.r30">[30]</xref>&#x000a0;In addition, baseline fasting serum lipid levels should be measured at treatment initiation and then every 1 to 2 weeks during therapy until they stabilize.</p>
        <p>Patients with a history of kidney disease and undergoing etretinate therapy should regularly monitor their renal function throughout the treatment course.<xref ref-type="bibr" rid="article-31212.r17">[17]</xref></p>
      </sec>
      <sec id="article-31212.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of systemic vitamin A toxicity includes discontinuing vitamin A intake, providing supportive care, and managing patient symptoms.</p>
        <p>The management of skin irritation caused by topical retinoids involves reducing the volume and frequency of applications while increasing the use of emollients. Patients can be reassured that this adverse effect will likely improve with the continued use of the skincare products.</p>
        <p>Acute retinoid toxicity is rare, but in documented cases, recovery is typically rapid upon discontinuation of the medication.<xref ref-type="bibr" rid="article-31212.r31">[31]</xref> The sources of excess vitamin A intake, including dietary supplements and medications, must be identified as a primary step. Furthermore, healthcare professionals should recommend avoiding foods rich in preformed vitamin A to patients, such as liver and fortified products, until the toxicity resolves.</p>
        <p>Supportive care involves close monitoring of the patient's condition,&#x000a0;including vital signs and overall health status. Severe cases may necessitate hospital admission. Hypotension can be managed with fluid administration, and hypercalcemia can be treated with calcitonin and corticosteroids.&#x000a0;When there is evidence of&#x000a0;hepatic damage, liver function tests&#x000a0;can assess the extent of the injury and guide further management decisions.</p>
        <p>Patients with dry or peeling skin are advised to use moisturizers or emollients to alleviate discomfort and facilitate skin healing. For patients experiencing dry eyes, artificial tears and lubricating eye drops, including those containing methylcellulose, can be beneficial.&#x000a0;</p>
        <p>The treatment of medication-induced chronic toxicity depends on the specific drug and its adverse effects. In cases where oral retinoids can lead to an elevation of the fasting triglyceride level to 800 mcg/dL or higher, options such as discontinuation, dose reduction, or the addition of lipid-lowering medication can be considered to prevent pancreatitis. Milder elevations can be monitored or treated similarly.</p>
        <p>Patients experiencing toxicity from bexarotene can consider using a statin or fibrate concurrently to manage retinoid-induced hyperlipidemia and lower the risk of pancreatitis. Therapy may need to be discontinued if values remain elevated despite intervention and exceed 3 times the upper limit of normal.<xref ref-type="bibr" rid="article-31212.r32">[32]</xref></p>
        <p>Patients diagnosed with pseudotumor cerebri syndrome should discontinue using vitamin A medications&#x000a0;and might need acetazolamide to lower the intracranial pressure.<xref ref-type="bibr" rid="article-31212.r15">[15]</xref></p>
        <p>Teratogenic malformations result in permanent damage, and the necessary supportive or surgical care varies based on the affected organ system.</p>
      </sec>
      <sec id="article-31212.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When assessing the differential diagnosis of hypervitaminosis A, it is crucial to exclude other conditions that might manifest with similar symptoms, some of which are listed below.</p>
        <p><bold>Acute liver injury:</bold> Viral hepatitis, alcohol use, or drug toxicity.</p>
        <p><bold>Hypercalcemia:</bold> Hyperparathyroidism, malignancy, or excessive calcium and vitamin D intake.</p>
        <p><bold>Hypothyroidism:</bold> Primary thyroid disorders or medications.</p>
        <p><bold>Chronic renal failure:</bold> Diabetes, hypertension, glomerulonephritis, or polycystic kidney disease.</p>
        <p><bold>Central nervous system:</bold>&#x000a0;Headache, nausea, and vomiting may be symptoms of pseudotumor cerebri and are not always caused by vitamin A toxicity.</p>
        <p><bold>Dermatological conditions:</bold> Exfoliative dermatitis and other skin conditions.</p>
        <p><bold>Nonspecific&#x000a0;symptoms:</bold>&#x000a0;The nonspecific symptoms, including skin rashes, joint pain, fatigue, and renal and liver abnormalities, can also indicate conditions such as systemic lupus erythematosus and may not solely point to vitamin A toxicity.</p>
      </sec>
      <sec id="article-31212.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of hypervitaminosis A depends on the severity of the condition and the duration of exposure to high levels of vitamin A. In most patients who discontinue the source of excess vitamin A, toxicity symptoms gradually reverse, and complete recovery is&#x000a0;expected. Symptoms such as dry skin, headache, and nausea typically improve within a few weeks or months with no long-term complications.</p>
        <p>However, severe cases can have serious&#x000a0;consequences. Prolonged and excessive vitamin A intake can result in significant organ damage, including the liver, bones, central nervous system, and skin. Liver&#x000a0;fibrosis or cirrhosis may be irreversible. Bone abnormalities, such as&#x000a0;reduced bone density or fractures, may persist even after discontinuing vitamin A intake. In cases of pseudotumor cerebri, visual impairment may be permanent. The prognosis depends on the extent of organ damage and the promptness of medical intervention.</p>
      </sec>
      <sec id="article-31212.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of vitamin A toxicity&#x000a0;include those listed below.&#x000a0;</p>
        <p><bold>Acute toxicity:</bold> Nausea, vomiting, headache, dizziness, irritability, blurred vision, and intracranial hypertension</p>
        <p><bold>Chronic toxicity:</bold> Dry, itchy skin, hair loss, bone and joint pain, fatigue, anorexia, and weight loss</p>
        <p><bold>Teratogenic effects:</bold> Craniofacial abnormalities, central nervous system malformations, and cardiovascular malformations</p>
        <p><bold>Hepatic toxicity:</bold>&#x000a0;Hepatomegaly, elevated liver enzymes, jaundice, fibrosis, and cirrhosis</p>
        <p><bold>Skeletal abnormalities:</bold> Increased bone resorption, decreased bone formation, osteoporosis, fractures, and bone pain</p>
        <p><bold>Hematological disturbances:</bold>&#x000a0;Leukocytosis, anemia, and thrombocytopenia</p>
        <p><bold>Central nervous system:</bold> Pseudotumor cerebri, with symptoms of headache, visual disturbances, and papilledema</p>
      </sec>
      <sec id="article-31212.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education regarding vitamin A toxicity is a shared responsibility among healthcare professionals, including physicians, advanced care practitioners, registered dietitians, nurses, and pharmacists. The significance of maintaining a balanced diet that includes essential vitamins and minerals is emphasized during routine medical appointments. Information regarding dietary sources of vitamin A, such as liver, fish, eggs, dairy products, and colorful fruits and vegetables, is provided to patients.&#x000a0;Clinicians should advise patients&#x000a0;about their recommended daily vitamin A intake according to their age, sex, and overall health.</p>
        <p>Pharmacists provide information about both over-the-counter and prescription drugs containing vitamin A or its derivatives, including retinoids. They can elucidate the proper usage and potential adverse effects of these medications, underscoring the significance of adhering to the recommended dosage and treatment duration.</p>
        <p>Obstetricians and other clinicians responsible for caring for women of childbearing age are responsible for educating them about the risks associated with excessive vitamin A intake from supplements or medications during pregnancy and the potential for teratogenic effects.&#x000a0;</p>
        <p>If clinicians suspect toxicity, they should communicate the possible complications to patients and recommend discontinuing sources of vitamin A. This may involve dietary modifications and adjustments to medication and supplement usage.</p>
      </sec>
      <sec id="article-31212.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Teratogenicity is the most significant adverse effect of vitamin A toxicity. To mitigate this risk, patients should be counseled to avoid consuming more than the recommended amount of supplemental vitamin A during pregnancy. Most other adverse effects, such as skin irritation, dryness, and increased intracranial pressure, typically resolve when vitamin A intake or application is reduced or discontinued. Elevated triglycerides, cholesterol, or transaminases generally show improvement even with the continued use of the medication. Nevertheless, these levels should be closely monitored, and treatment should be discontinued if elevations persist or worsen.</p>
      </sec>
      <sec id="article-31212.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Many&#x000a0;individuals regularly consume substantial amounts of vitamins and supplements, often assuming they are safe due to their over-the-counter availability.&#x000a0;However, poison control centers receive thousands of calls yearly related to vitamin overdoses and potential toxicity. An interprofessional team can collaborate to educate the public about these risks.</p>
        <p>Healthcare professionals, including physicians, nurses, and pharmacists, must possess a comprehensive skill set to address vitamin A toxicity effectively. Pharmacists are critical in disseminating vitamin safety information to the public, advocating for a balanced, healthy diet over supplement reliance.&#x000a0;They also instruct consumers about the vitamin A content in both over-the-counter and prescription medications. The nursing staff encourages patients to consume a healthy diet and refrain from taking&#x000a0;vitamin A supplements unless advised by their medical provider. Primary care physicians should collaborate with nurses and pharmacists to ensure that patients maintain safe levels of vitamin A intake from dietary sources, supplements, and medications.&#x000a0;</p>
        <p>Pregnancy is an absolute contraindication for isotretinoin therapy. Despite this, patients may still take other retinoid medications and supplements that have teratogenic effects. The nursing and medical staff, along with obstetricians and clinicians, are responsible for obtaining and coordinating patients' medication history, ensuring thorough documentation and periodic review of all medications, vitamins, and supplements. Patients should be informed about the teratogenic risks associated with excessive vitamin A intake and provided with guidance on the maximum recommended dosages during pregnancy.</p>
        <p>By combining these skills, strategic approaches, shared responsibilities, effective communication, and seamless care coordination, healthcare professionals can deliver patient-centered care, optimize outcomes, enhance patient safety, and improve overall interprofessional team performance when managing vitamin A toxicity.</p>
      </sec>
      <sec id="article-31212.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31212&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31212">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nutrition/vitamin-a-toxicity/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31212">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31212/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31212">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31212.s18">
        <title>References</title>
        <ref id="article-31212.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunt</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Teratogenicity of high vitamin A intake.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>May</month>
            <day>02</day>
            <volume>334</volume>
            <issue>18</issue>
            <fpage>1197</fpage>
            <pub-id pub-id-type="pmid">8602195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strobel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tinz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Biesalski</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>The importance of beta-carotene as a source of vitamin A with special regard to pregnant and breastfeeding women.</article-title>
            <source>Eur J Nutr</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>46 Suppl 1</volume>
            <fpage>I1</fpage>
            <page-range>I1-20</page-range>
            <pub-id pub-id-type="pmid">17665093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bastos Maia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rolland Souza</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Costa Caminha</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Lins da Silva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Callou Cruz</surname>
                <given-names>RSBL</given-names>
              </name>
              <name>
                <surname>Carvalho Dos Santos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Batista Filho</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A and Pregnancy: A Narrative Review.</article-title>
            <source>Nutrients</source>
            <year>2019</year>
            <month>Mar</month>
            <day>22</day>
            <volume>11</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30909386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Penniston</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Tanumihardjo</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The acute and chronic toxic effects of vitamin A.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-201</page-range>
            <pub-id pub-id-type="pmid">16469975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lammer</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Hoar</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Agnish</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Benke</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fernhoff</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Grix</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Lott</surname>
                <given-names>IT</given-names>
              </name>
            </person-group>
            <article-title>Retinoic acid embryopathy.</article-title>
            <source>N Engl J Med</source>
            <year>1985</year>
            <month>Oct</month>
            <day>03</day>
            <volume>313</volume>
            <issue>14</issue>
            <fpage>837</fpage>
            <page-range>837-41</page-range>
            <pub-id pub-id-type="pmid">3162101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lagac&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oskoui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Not a Benign Vitamin: Infant with Vitamin A Toxicity and Acute Intracranial Hypertension.</article-title>
            <source>Can J Neurol Sci</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>308</fpage>
            <page-range>308-309</page-range>
            <pub-id pub-id-type="pmid">36503562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sauvant</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>F&#x000e9;art</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Atgi&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A supply to mothers and children: challenges and opportunities.</article-title>
            <source>Curr Opin Clin Nutr Metab Care</source>
            <year>2012</year>
            <month>May</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>310</fpage>
            <page-range>310-4</page-range>
            <pub-id pub-id-type="pmid">22406743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arlappa</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A supplementation policy: A shift from universal to geographical targeted approach in India considered detrimental to health and nutritional status of under 5 years children.</article-title>
            <source>Eur J Clin Nutr</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">35347255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ball</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Furr</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Acyl coenzyme A:retinol acyltransferase activity and the vitamin A content of polar bear (Ursus maritimus) liver.</article-title>
            <source>Comp Biochem Physiol B</source>
            <year>1986</year>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>513</fpage>
            <page-range>513-7</page-range>
            <pub-id pub-id-type="pmid">3757481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senoo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mezaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morii</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blomhoff</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Accumulation of vitamin A in the hepatic stellate cell of arctic top predators.</article-title>
            <source>Anat Rec (Hoboken)</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>295</volume>
            <issue>10</issue>
            <fpage>1660</fpage>
            <page-range>1660-8</page-range>
            <pub-id pub-id-type="pmid">22907891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahoney</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Knauss</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Labbe</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Chronic vitamin A intoxication in infants fed chicken liver.</article-title>
            <source>Pediatrics</source>
            <year>1980</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>893</fpage>
            <page-range>893-7</page-range>
            <pub-id pub-id-type="pmid">7189278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horowitz</surname>
                <given-names>BZ</given-names>
              </name>
            </person-group>
            <article-title>Did hypervitaminosis A have a role in Mawson's ill-fated Antarctic exploration?</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>11</issue>
            <fpage>1277</fpage>
            <page-range>1277-1281</page-range>
            <pub-id pub-id-type="pmid">36286587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheven</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Retinoic acid and 1,25-dihydroxyvitamin D3 stimulate osteoclast formation by different mechanisms.</article-title>
            <source>Bone</source>
            <year>1990</year>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-9</page-range>
            <pub-id pub-id-type="pmid">2331432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Genaro</surname>
                <given-names>Pde S</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A supplementation and risk of skeletal fracture.</article-title>
            <source>Nutr Rev</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>65</fpage>
            <page-range>65-7</page-range>
            <pub-id pub-id-type="pmid">15080368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chisholm</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Abou-Jaoude</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hessler</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Sudhakar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review.</article-title>
            <source>Neuroophthalmology</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>169</fpage>
            <page-range>169-175</page-range>
            <pub-id pub-id-type="pmid">29796052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherman</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Gopal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haugen</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Whaley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nowlakha</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Duvic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Central hypothyroidism associated with retinoid X receptor-selective ligands.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>Apr</month>
            <day>08</day>
            <volume>340</volume>
            <issue>14</issue>
            <fpage>1075</fpage>
            <page-range>1075-9</page-range>
            <pub-id pub-id-type="pmid">10194237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cribier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Welsch</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heid</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Renal impairment probably induced by etretinate.</article-title>
            <source>Dermatology</source>
            <year>1992</year>
            <volume>185</volume>
            <issue>4</issue>
            <fpage>266</fpage>
            <page-range>266-8</page-range>
            <pub-id pub-id-type="pmid">1477420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Gambla</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Advances in psoriasis therapy.</article-title>
            <source>Adv Dermatol</source>
            <year>1997</year>
            <volume>12</volume>
            <fpage>47</fpage>
            <page-range>47-72; discussion 73</page-range>
            <pub-id pub-id-type="pmid">8973735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duvic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Crowley</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Yocum</surname>
                <given-names>RC</given-names>
              </name>
              <collab>Worldwide Bexarotene Study Group</collab>
            </person-group>
            <article-title>Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.</article-title>
            <source>Arch Dermatol</source>
            <year>2001</year>
            <month>May</month>
            <volume>137</volume>
            <issue>5</issue>
            <fpage>581</fpage>
            <page-range>581-93</page-range>
            <pub-id pub-id-type="pmid">11346336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nollevaux</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Guiot</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Horsmans</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Leclercq</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rahier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Geubel</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sempoux</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption.</article-title>
            <source>Liver Int</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-6</page-range>
            <pub-id pub-id-type="pmid">16448456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bigby</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Does isotretinoin increase the risk of depression?</article-title>
            <source>Arch Dermatol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>144</volume>
            <issue>9</issue>
            <fpage>1197</fpage>
            <page-range>1197-9; discussion 1234-5</page-range>
            <pub-id pub-id-type="pmid">18794466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rothman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>US</given-names>
              </name>
              <name>
                <surname>Mannino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Milunsky</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Teratogenicity of high vitamin A intake.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Nov</month>
            <day>23</day>
            <volume>333</volume>
            <issue>21</issue>
            <fpage>1369</fpage>
            <page-range>1369-73</page-range>
            <pub-id pub-id-type="pmid">7477116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marshall</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Studer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>P&#x000f6;pperl</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aparicio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuroiwa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krumlauf</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A conserved retinoic acid response element required for early expression of the homeobox gene Hoxb-1.</article-title>
            <source>Nature</source>
            <year>1994</year>
            <month>Aug</month>
            <day>18</day>
            <volume>370</volume>
            <issue>6490</issue>
            <fpage>567</fpage>
            <page-range>567-71</page-range>
            <pub-id pub-id-type="pmid">7914354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inkeles</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Connor</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Illingworth</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Hepatic and dermatologic manifestations of chronic hypervitaminosis A in adults. Report of two cases.</article-title>
            <source>Am J Med</source>
            <year>1986</year>
            <month>Mar</month>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>491</fpage>
            <page-range>491-6</page-range>
            <pub-id pub-id-type="pmid">2937294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Weiskirchen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Weiskirchen</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A: too good to be bad?</article-title>
            <source>Front Pharmacol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1186336</fpage>
            <pub-id pub-id-type="pmid">37284305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moise</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Noy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Palczewski</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Blaner</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Delivery of retinoid-based therapies to target tissues.</article-title>
            <source>Biochemistry</source>
            <year>2007</year>
            <month>Apr</month>
            <day>17</day>
            <volume>46</volume>
            <issue>15</issue>
            <fpage>4449</fpage>
            <page-range>4449-58</page-range>
            <pub-id pub-id-type="pmid">17378589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldsmith</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Bolognia</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Callen</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Lucky</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Siegfried</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Thiboutot</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wheeland</surname>
                <given-names>RG</given-names>
              </name>
              <collab>American Academy of Dermatology</collab>
            </person-group>
            <article-title>American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>6</issue>
            <fpage>900</fpage>
            <page-range>900-6</page-range>
            <pub-id pub-id-type="pmid">15153892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sammartano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bertoncini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Barbuti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ippolito</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A suspected hypervitaminosis A.</article-title>
            <source>Acta Biomed</source>
            <year>2023</year>
            <month>Jun</month>
            <day>14</day>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>e2023098</fpage>
            <pub-id pub-id-type="pmid">37326274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Perche</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>The use of oral vitamin A in acne management: a review.</article-title>
            <source>Dermatol Online J</source>
            <year>2022</year>
            <month>Oct</month>
            <day>15</day>
            <volume>28</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">36809126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gniadecki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Assaf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bagot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dummer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Duvic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knobler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ranki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwandt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Whittaker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The optimal use of bexarotene in cutaneous T-cell lymphoma.</article-title>
            <source>Br J Dermatol</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>433</fpage>
            <page-range>433-40</page-range>
            <pub-id pub-id-type="pmid">17553039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hosaka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Amagasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vitamin A toxicity secondary to excessive intake of yellow-green vegetables, liver and laver.</article-title>
            <source>J Hepatol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-8</page-range>
            <pub-id pub-id-type="pmid">10424294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31212.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiegand</surname>
                <given-names>UW</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics of acitretin and etretinate.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>2 Pt 3</issue>
            <fpage>S25</fpage>
            <page-range>S25-33</page-range>
            <pub-id pub-id-type="pmid">9703120</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
